Opening Avenues for Rheumatoid Arthritis Treatment via Transdermal Application of Microneedles: Progress so far and Future Outlook.
Rheumatoid arthritis (RA) is a chronic autoimmune disease with a global prevalence of 0.5% to 2%, causing serious impairment and early mortality. Presently approved therapeutics comprising non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), corticosteroids, etc. only lower p...